109 related articles for article (PubMed ID: 32963350)
21. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.
Gógl G; Alexa A; Kiss B; Katona G; Kovács M; Bodor A; Reményi A; Nyitray L
J Biol Chem; 2016 Jan; 291(1):11-27. PubMed ID: 26527685
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1/ERK1/2/RSK1 pathway.
Cai W; Zhong S; Zheng F; Zhang Y; Gao F; Xu H; Cai X; Lan J; Huang D; Shi G
IUBMB Life; 2019 Feb; 71(2):261-276. PubMed ID: 30452117
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity.
Cheng C; Yun F; Ullah S; Yuan Q
Eur J Med Chem; 2020 Mar; 189():112073. PubMed ID: 31991336
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
Shiota M; Yokomizo A; Takeuchi A; Itsumi M; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Prostate; 2014 Jun; 74(9):959-69. PubMed ID: 24740858
[TBL] [Abstract][Full Text] [Related]
28. The soy-derived peptide Vglycin inhibits the growth of colon cancer cells in vitro and in vivo.
Gao C; Sun R; Xie YR; Jiang AL; Lin M; Li M; Chen ZW; Zhang P; Jin H; Feng JP
Exp Biol Med (Maywood); 2017 May; 242(10):1034-1043. PubMed ID: 28492347
[TBL] [Abstract][Full Text] [Related]
29. 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.
Hu Y; Fang X; Dunham SM; Prada C; Stachowiak EK; Stachowiak MK
J Biol Chem; 2004 Jul; 279(28):29325-35. PubMed ID: 15117958
[TBL] [Abstract][Full Text] [Related]
30. Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis.
D'Andrea MR; Mei JM; Tuman RW; Galemmo RA; Johnson DL
Mol Cancer Ther; 2005 Aug; 4(8):1198-204. PubMed ID: 16093435
[TBL] [Abstract][Full Text] [Related]
31. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.
Xie X; Liu K; Liu F; Chen H; Wang X; Zu X; Ma X; Wang T; Wu Q; Zheng Y; Bode AM; Dong Z; Kim DJ
Cancer Lett; 2019 Feb; 442():126-136. PubMed ID: 30391783
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.
Gupta J; Igea A; Papaioannou M; Lopez-Casas PP; Llonch E; Hidalgo M; Gorgoulis VG; Nebreda AR
Oncotarget; 2015 Apr; 6(11):8539-51. PubMed ID: 25890501
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
34. mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation.
He K; Zheng X; Li M; Zhang L; Yu J
Oncogene; 2016 Jan; 35(2):148-57. PubMed ID: 25867072
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Zhang L; Fan J; Chong JH; Cesena A; Tam BY; Gilson C; Boykin C; Wang D; Aivazian D; Marcotte D; Xiao G; Le Brazidec JY; Piao J; Lundgren K; Hong K; Vu K; Nguyen K; Gan LS; Silvian L; Ling L; Teng M; Reff M; Takeda N; Timple N; Wang Q; Morena R; Khan S; Zhao S; Li T; Lee WC; Taveras AG; Chao J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5633-7. PubMed ID: 21798738
[TBL] [Abstract][Full Text] [Related]
37. SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
Patyna S; Laird AD; Mendel DB; O'farrell AM; Liang C; Guan H; Vojkovsky T; Vasile S; Wang X; Chen J; Grazzini M; Yang CY; Haznedar JO; Sukbuntherng J; Zhong WZ; Cherrington JM; Hu-Lowe D
Mol Cancer Ther; 2006 Jul; 5(7):1774-82. PubMed ID: 16891463
[TBL] [Abstract][Full Text] [Related]
38. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
[TBL] [Abstract][Full Text] [Related]
40.
Bhagat M; Kumar A; Suravajhala R
Curr Top Med Chem; 2020; 20(22):1981-1992. PubMed ID: 32703136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
